TheraPten Biosciences Inc. — Form D
TheraPten Biosciences Inc. of KELOWNA, A1, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-24. The offering totals $500K, of which $500K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-01-24
- Form: D
- Accession: 0001085037-18-000013
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $500K
- Investors: 1
- Date of first sale: 2018-01-04
- Security types: equity
- Revenue range: Not Applicable
- SEC file number: 021-304009
Issuer
- Name: TheraPten Biosciences Inc.
- CIK: 0001728964
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Incorporated: 2016
- Address: 101 -1865 DILWORTH DRIVE, KELOWNA, A1, V1Y 9T1
- Phone: 250-864-2740
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Harvey Lalach | Director | Kelowna, A1 |
| Harvey Lalach | Executive Officer | Kelowna, A1 |
| Yiannis Monovoukas | Director | Cambridge, MA |
| Athanasios Alevizopoulos | Director | Yverdon-les-Bains, V8 |
| Athanasios Alevizopoulos | Executive Officer | Yverdon-les-Bains, V8 |
| Harvey Lach | Director | Kelowna, A1 |
| Harvey Lach | Executive Officer | Kelowna, A1 |
| Kyriakoulis Paganis | Director | Anavyssos, J3 |
Other filings by this issuer (1)
More